在移植中利用HCV-Viremic捐赠者的区域差异和时间变化
Napat Leeaphorn1, Rose Mary Attieh1, Hani M Wadei1
1Department of Transplant, Mayo Clinic, Jacksonville, Florida, USA.
Transplantation proceedings
|July 13, 2024
概括
肝炎C病毒 (HCV) 病毒性脏在美国显示区域利用差异. 越来越多地采用HCV供体脏移植用于NAT阴性接受者,这表明未来更公平的获取.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植 移植 移植 移植
- 传染性疾病 传染性疾病
背景情况:
- 型肝炎病毒 (HCV) 病毒性脏越来越多地被使用,但并不被普遍接受.
- 区域差异和它们使用的时间变化需要调查.
研究的目的:
- 识别和分析美国各地使用HCV病毒性脏的区域差异.
- 检查HCV病毒性捐赠移植到HCVNAT阴性接受者 (HCV D+/R-移植) 的时间趋势.
主要方法:
- 对器官采购和移植网络数据库的分析 (2019年3月-2023年3月).
- 美国地区对HCV病毒性脏利用率的检查.
- 使用基尼系数评估HCV D+/R-移植的中心级聚类和分布.
主要成果:
- 观察到HCV病毒性脏利用率的区域差异很大,第3,10和11地区占利用率的51%.
- 第9地区从进口HCV病毒性脏中获得的收益最高 (284.9%),第8和第6地区的净损失最大 (分别为-44.2%和-41.1%).
- 起初,HCV D+/R-移植病例集中在高人数的中心,但随着时间的推移,病例呈现出更公平分配的趋势.
结论:
- 在美国,HCV病毒性脏利用率存在实质性的区域差异.
- 某些地区的移植中心可以采取政策来增加HCV病毒性脏的使用,并扩大他们的捐赠者池.
- 越来越多的人采用HCV D+/R-移植,这表明朝着更平衡地获得这些脏的进步.
相关概念视频
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...